Phreesia Inc (PHR)
24.28
+0.23
(+0.96%)
USD |
NYSE |
May 17, 16:00
24.28
0.00 (0.00%)
After-Hours: 20:00
Phreesia Gross Profit Margin (Quarterly): 66.56% for Jan. 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 66.56% |
October 31, 2023 | 66.23% |
July 31, 2023 | 64.70% |
April 30, 2023 | 63.03% |
January 31, 2023 | 63.49% |
October 31, 2022 | 62.61% |
July 31, 2022 | 59.59% |
April 30, 2022 | 58.10% |
January 31, 2022 | 61.47% |
October 31, 2021 | 62.28% |
July 31, 2021 | 61.42% |
April 30, 2021 | 62.19% |
Date | Value |
---|---|
January 31, 2021 | 64.64% |
October 31, 2020 | 63.60% |
July 31, 2020 | 65.67% |
April 30, 2020 | 65.32% |
January 31, 2020 | 65.95% |
October 31, 2019 | 65.62% |
July 31, 2019 | 63.30% |
April 30, 2019 | 61.34% |
January 31, 2019 | 62.03% |
October 31, 2018 | 62.85% |
July 31, 2018 | 63.96% |
April 30, 2018 | 63.08% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
58.10%
Minimum
Apr 2022
66.56%
Maximum
Jan 2024
63.46%
Average
63.49%
Median
Jan 2023
Gross Profit Margin (Quarterly) Benchmarks
Teladoc Health Inc | 69.89% |
American Shared Hospital Services | 49.42% |
Novo Integrated Sciences Inc | 41.76% |
Astrana Health Inc | 18.29% |
Cryo-Cell International Inc | 72.49% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -52.07% |
Return on Assets | -37.83% |
Return on Invested Capital | -51.93% |
Profit Margin (Quarterly) | -32.26% |
Operating Margin (Quarterly) | -31.13% |
Return on Net Operating Assets | -68.66% |